Effects of tumor necrosis factor-α and interleukin-6 on fluid-phase permeability and ammonia diffusion in CNS-derived endothelial cells

Journal of Investigative Medicine

Volumn 44, Issue 8, 1996, Pages 474-482

  Duchini, Andrea ^a   Govindarajan, Sugantha ^b   Santucci, Marco ^c   Zampi, Giancarlo ^c   Hofman, Florence M ^d  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Ammonia; Blood brain barrier; CNS endothelial cells; Cytokines; Permeabil ity

Indexed keywords

AMMONIA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DRUG EFFECT; ELECTRON MICROSCOPY; ENDOTHELIUM; HUMAN; METABOLISM; PERMEABILITY; PHYSIOLOGY; ULTRASTRUCTURE;

AMMONIA; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; ENDOTHELIUM; HUMANS; INTERLEUKIN-6; MICROSCOPY, ELECTRON; PERMEABILITY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030253214     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Power C, Kong PA, Crawford TO, Wesselingh S, Glass JD, McArthur JC, Trapp BD. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol 1993;34:339-50.
2. Petito CK, Cash KS. Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992;32(5):658-66.
3. Rhodes RH. Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 1991;50(2):171-83.
4. McLean BN, Zeman AZJ, Barnes D, Thompson EJ. Patterns of blood-brain barrier impairment and clinical features in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993;56(4):356-60.
5. Sharieff MK, Thompson EJ. In vivo relationship of tumor necrosis factor to blood-brain barrier damage in patients with active multiple sclerosis. J Neuroimmunol 1992;38:27-34.
6. Achim CL, Heyes MP, Wiley CA. Quantitation of immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest 1993;91:2769-75.
7. Wesselingh SL, Power C, Glass JD, Tyor WR, McArthur JC, Farber JM, Griffin JW, Griffin DE. Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann Neurol 1993;33:576-82.
8. Stellen M, Reinecker HC, Petersen J, Doehn C, Pflueger I, Voss A. Raedler A. Differences in cytokine secretion by intestinal mononuclear cells, peripheral blood monocytes, and alveolar macrophages from HIV-infected patients. Clin Exp Immunol 1993;91:30-6.
9. Sharieff MK, Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med 1991;15:325(7):467-72.
10. Hofman FM, Hinton DR, Johnson K, Merrill JE. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 1989;170:607-12.
11. Hartung HP, Jung S, Stoll G, Zielasek J, Schmidt B, Archelos JJ, Toyka KV. Inflammatory mediators in demyelinating disorders of the CNS and PNS. J Neuroimmunol 1992;40:197-210.
12. Pober JS. Cytokine-mediated activation of vascular endothelium. Am J Pathol 1988;133(3):426-33.
13. Camussi G, Turello E, Bussolino F, Baglioni C. Tumor necrosis factor alters cytoskeletal organization and barrier function of endothelial cells. Int Arch Allergy Appl Immunol 1991;96:84-91.
14. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM. Exogenous tat protein activates human endothelial cells. Blood 1993;82:2774-80.
15. Maruo N, Morita I, Shirao M, Murota SI. IL-6 increases endothelial endothelial permeability in vitro. Endocrinology 1992;131:710-4.
16. Goldstein GW, Betz AL. The blood-brain barrier. Sci Am 1986;255:74-83.
17. Hofman FM, Dohadwala MM, Wright AD, Hinton DR, Walker SM. Exogenous tat protein activates nervous system-derived endothelial cells. J Neuroimmunol 1994;54:19-28.
18. Jaffe EA, Nachman RL, Becker DG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973;52:2745-51.
19. Simionescu M, Ghitescu L, Fixman A, Simionescu N. How plasma macromolecules cross the endothelium. News in Physiological Sciences 1987;2:97-100.
20. Pardridge WM, Boads RJ. Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. FEES Lett 1991;288:30-2.
21. Pardridge WM, Triguero D, Buciak JL, Yang J. Evaluation of cationized rat-albumin as a potential blood-brain barrier drug transport vector. J Pharmacol Exp Ther 1990;255:893-9.
22. Reese T, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967;34:207-17.
23. Connell CJ, Mercer KL. Freeze-fracture appearance of the capillary endothelium in the cerebral cortex of mouse brain. Amer J Anat 1974.;140:595-600.
24. Potvin M, Finlayson MH, Hinchey EJ, Lough JO, Goresky CA. Cerebral abnormalities in hepatectomized rats with acute hepatic coma. Lab Invest 1984;55(5):560-4.
25. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992;15:1060-6.
26. Schafer DF. The blood-brain barrier in acute liver failure. In: Advances in hepatic encephalopathy and urea cycle diseases. Kleinberger G, Ferenci P, Riederer P, Thaler H, eds. Vienna: Karger 1984;232-9.
27. Westergard E, Van Deurs B, Bondsted HE. Increased vesicular transfer of horseradish peroxidase across cerebral endothelium, evoked by acute hypertension. Acta Neuropathol (Berl) 1977;37:141-52.
28. Shivers R, Edmonds C, Del Maestro R. Microvascular permeability in induced astrocytoma and peritumor neuropil of rat brain. Acta Neuropathol 1984;64; 192-202.
29. Weller R, Foy M, Cox S. The development and ultrastructure of the microvasculature in malignant gliomas. Neuropathol Appl Neurobiol 1977;3:307-22.
30. Persson L, Hansson HA. Reversible blood-brain barrier dysfunction to peroxidase after a small stab wound in the rat cerebral cortex. Acta Neuropathol (Berl) 1976;35:333-42.
31. Povlishock JT, Becker DP, Sullivan HG, Miller JD. Vascular permeability alterations to horseradish peroxidase in experimental brain injury. Brain Res 1978;153; 222-31.
32. Stolpen AH, Guinon EC, Fiers W, Pober JS. Recombinant tumor necrosis factor and immune interferon act singly and in combination to reorganize human vascular endothelial cell moiolayers. Am J Pathol 1986;123:16-23.
33. Langeier EG, Fiers W, Van Hinsberg VWM. Effects of tumor necrosis factor on prostacyclin production and the barrier function of human endothelial cell monolayers. Arterioscler Thromb 1991;11:872-81.
34. Saukkonen K, Sande S, Cioffe C, Wolpe S, Sherry B, Cerami A, Tuomanen E. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J Exp Med 1990;171:439-49.
35. Megyeri P, Abraham CS, Temesvari P, Kovacs J, Vas T, Speer CP. Recombinant tumor necrosis factor constricts pial arterioles and increases blood-brain barrier permeability in newborn piglets. Neurosci Lett 1992;148:137-40.
36. Kim KS, Wass CA, Cross AS, Opal SM. Modulation of blood-brain barrier permeability by tumor necrosis factor in the rat. Lymphokine Cytokine Res 1992;11:293-8.
37. Royall JA, Berkow RL, Beckman JS, Cunningham MK, Matalon S, Freeman BA. Tumor necrosis factor and interleukin-1 increase vascular endothelial permeability. Am J Physiol 1989;257:L399-L410.
38. Goldblum SE, Sun WL. TNF augments pulmonary arterial transendothelial albumin flux in vitro. Am J Physiol 1990;258:257-67.
39. Gibbs LS, Lai L, Malik AB. Tumor necrosis factor enhances the neutrophil-dependent increase in endothelial permeability. J Cell Physiol 1990;145:496-500.
40. Pekala P, Marlow M, Heuvelman D, Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor - but not by insulin. J Biol Chem 1990;265(30): 18051-4.
41. Moser R, Schleiffenbaum B, Groscurth P, Fehr J. Interleukin-1 and tumor necrosis factor stimulate human vascular endothelial cells to promote neutrophil passage. J Clin Invest 1989;82:444-55.
42. Beynon HLC, Haskard DO, Davies KA, Haroutunian R, Walport MJ. Combinations of low concentrations of cytokines and acute agonists synergize in increasing the permeability of endothelial monolayers. Clin Exp Immunol 1993;91:314-9.
43. Gaffney AB, Keenan AK. Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 α/β, tumor necrosis factor-α and interferon-γ. Immunopharmacology 1993;25:1-9.
44. Pardridge WM. Peptide drug delivery to the brain. New York: Raven Press, 1991;149-218.
45. Klein NJ, Shennan GI, Heyderman RS, Levin M. Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin, and neutrophils. J Cell Sci 1992;102:821-31.
46. Long D. Capillary ultrastructure and the blood-brain barrier in human malignant brain tumors. J Neurosurg 1970; 32:127-44.
47. Greig N, Jones H, Lavanagh J. Blood-brain barrier integrity and host response in experimental metastatic brain tumors. Clin Exp Metastasis 1983;1:229-46.
48. Cox D, Pilkington G, Lantos P. The fine structure of blood vessels in ethylnitrosourea-induced tumors of the rat nervous system. With special reference to the breakdown of the blood-brain barrier. Br J Exp Pathol 1976;57:419-30.
49. Hirano A, Matsui T. Vascular structures in brain tumors. Hum Pathol 1975;6:611-21.
50. Waggener J, Beggs J. Vasculature of neural neoplasms. Adv Neurol 1976;15:27-49.
51. Lossinsky AS, Vorbrodt AW, Wisniewski HM. Scanning and transmission electron microscopic studies of microvascular pathology in the osmotically impaired blood-brain barrier. J Neurocytol 1995; 24:795-806.